NAICS 541715: Research and Development in the Physical
This U.S. industry comprises establishments primarily engaged in conducting research and experimental development (except nanotechnology and biotechnology research and experimental development) in the physical, engineering, and life sciences, such as agriculture, electronics, environmental, biology, botany, computers, chemistry, food, fisheries, forests, geology, health, mathematics, medicine, oceanography, pharmacy, physics, veterinary, and other allied subjects.

ExioML sector: Research and development services (73)
Region: US | Year: 2022
Sector value added: 101689.895384 M EUR | Employment: 9284.95382206 thousand persons
Sector GHG emissions: 1501417868.95 kg CO2 eq | Energy carrier net total: 142153.6007 TJ | Carbon intensity: 0.014764671192554249

Company: Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals Inc. develops, manufactures, and markets pharmaceutical products. The Company offers products for prevention of infectious diseases, cancer, depression, cardiovascular, and gastrointestinal diseases.